47 completed, 9 unknown, 7 terminated, 2 withdrawn. 21 Phase 1, 13 Phase 2, 5 Not applicable, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 21 | Completed 18, Terminated 2, Withdrawn 1 |
| Phase 2 | 13 | Completed 9, Terminated 4 |
| Not applicable | 5 | Unknown 3, Completed 1, Terminated 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow Mass Spectrometry: new trials by email Literature Review of Mass Spectrometry trials Research Report on Mass Spectrometry
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Monitoring MRD in Multiple Myeloma in Serum by Mass Spectrometry Mass spectrometry - Multiple Myeloma, Minimal Residual Disease | Not yet recruiting | Odense University Hospital | 40 | 2026-08-04 | 2026-07-08 | |
| Histiocytosis in Injecting Drug Users Chitotriosidase, Mass spectrometry, scanning electron microscope with energy-dispersive X-ray spectroscopy - Histiocytosis | Enrolling by invitation | Tampere University Hospital | 30 | 2023-05-29 | 2025-09-10 | |
| Finding New Targets by Proteomic Approaches (InnovRT1) Mass spectrometry - ATRT | Completed | Assistance Publique - Hôpitaux de Paris | 44 | 2022-08-12 | 2026-10-05 | |
| Rapid Diagnostic Test for Septic Arthritis Mass spectrometry - Juvenile Idiopathic Arthritis, Arthritis, Septic | Completed | Assistance Publique - Hôpitaux de Paris | 274 | 2021-05-06 | 2023-01-04 | |
| Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection. Volatile Organic Compounds analysis (e-noses), Canine odor detection of Volatile Organic Compounds, Volatile Organic Compounds analysis (mass spectrometry) - Covid19 | Not applicable | Unknown | Hopital Foch | 192 | 2021-03-01 | 2022-08-03 |
| Hepatobiliary Tumors Tissue Samples Acquisition Gene expression analysis, Genomic analysis, Protein expression analysis - Hepatocellular Carcinoma, Cholangiocarcinoma | Unknown | Peking Union Medical College Hospital | 450 | 2020-10-11 | 2023-07-07 | |
| Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique Mass spectrometry, Microarray assay - Septicemia | Not applicable | Unknown | Chiang Mai University | 200 | 2018-07-30 | 2018-07-11 |
| Genomic and Proteomic Study of Richter Syndrome (CGPSR) Whole exome sequencing., RNA sequencing, Mass spectrometry - Richter Syndrome | Unknown | Central Hospital, Nancy, France | 170 | 2017-09-06 | 2023-03-24 | |
| Mass Spectrometry in Single Bladder Cancer Cells mass spectrometry - Bladder Cancer | Completed | University of Oklahoma | 2 | 2017-07-01 | 2020-10-19 | |
| Embryo Selection by Metabolomic Profiling of Embryo Culture Medium With Mass Spectroscopy as an Adjunct to Morphology Morphology, Morphology and Mass Spectroscopy - Embryo Selection, IVF | Not applicable | Unknown | Istanbul University | 300 | 2016-10-01 | 2016-08-30 |
| Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia mutation analysis, protein analysis, laboratory biomarker analysis - Leukemia | Completed | Eastern Cooperative Oncology Group | 220 | 2012-01-03 | 2017-05-19 | |
| Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia gene expression analysis, gene rearrangement analysis, polymerase chain reaction - Leukemia | Completed | Children's Oncology Group | 20 | 2011-12-01 | 2016-05-18 | |
| Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma laboratory biomarker identification and analysis, biopsy, immunohistochemistry/tissue microarrays - Recurrent Melanoma, Stage IIIc Melanoma | Phase 2 | Terminated | Vanderbilt-Ingram Cancer Center | 12 | 2011-10-01 | 2016-05-30 |
| Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma RNA analysis, polymerase chain reaction, protein expression analysis - Neuroblastoma | Completed | Children's Oncology Group | 300 | 2011-06-01 | 2016-05-18 | |
| Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma gene expression analysis, immunohistochemistry staining method, laboratory biomarker analysis - Sarcoma | Completed | Children's Oncology Group | 60 | 2011-06-01 | 2016-05-19 | |
| Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies fludarabine phosphate, methoxyamine, laboratory biomarker analysis - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Completed | Case Comprehensive Cancer Center | 20 | 2011-05-01 | 2015-08-13 |
| Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma microarray analysis, protein expression analysis, western blotting - Lymphoma | Completed | Children's Oncology Group | 7 | 2011-05-01 | 2016-05-19 | |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases bafetinib, microdialysis, pharmacological study - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Phase 1 | Completed | City of Hope Medical Center | 7 | 2010-12-01 | 2018-04-17 |
| Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia entinostat, imatinib mesylate, laboratory biomarker analysis - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 2 | 2010-10-01 | 2017-08-08 |
| Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate panobinostat, everolimus, laboratory biomarker analysis - Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer | Phase 1 / Phase 2 | Terminated | Roswell Park Cancer Institute | 26 | 2010-03-01 | 2022-08-15 |
Showing 20 of 67. Sign in to see all of them.
Breast Neoplasms (16) · Carcinoma, Non-Small-Cell Lung (5) · Carcinoma, Ovarian Epithelial (5) · Lung Neoplasms (5) · Brain Neoplasms (4) · Breast Carcinoma In Situ (4) · Carcinoma, Intraductal, Noninfiltrating (4) · Colonic Neoplasms (4) · Colorectal Neoplasms (4) · Head and Neck Neoplasms (4) · Ovarian Neoplasms (4) · Prostatic Neoplasms (4) · Rectal Neoplasms (4) · Squamous Cell Carcinoma of Head and Neck (4) · Carcinoma, Hepatocellular (3)
City of Hope Medical Center (9) · Vanderbilt-Ingram Cancer Center (6) · Children's Oncology Group (4) · Abramson Cancer Center at Penn Medicine (3) · Mayo Clinic (3) · National Cancer Institute (NCI) (3) · Wake Forest University Health Sciences (3) · Assistance Publique - Hôpitaux de Paris (2) · Barbara Ann Karmanos Cancer Institute (2) · Case Comprehensive Cancer Center (2) · Children's Cancer and Leukaemia Group (2) · Roswell Park Cancer Institute (2) · University of Nebraska (2) · Cancer Research UK (1) · Cancer Trials Ireland (1)
United States (40) · United Kingdom (5) · France (4) · Ireland (3) · Belgium (1) · Canada (1) · China (1) · Finland (1) · Thailand (1) · Turkey (Türkiye) (1)
Ercole Cavalieri, DSc (2) · Frank M. Torti, MD, MPH (2) · Ravi Amaravadi, MD (2) · A. Bapsi Chakravarthy, MD (1) · Alan Boddy, PhD (1) · Allen E. Bale, MD (1) · Anthony Leathem, MD (1) · Barbara Murphy, MD (1) · Carlos L. Arteaga, MD (1) · Courtney DiNardo, MD (1) · David H. Ilson, MD, PhD (1) · Donald W. Northfeld, MD (1) · Eddy J. Estlin (1) · Edith A. Perez, MD (1) · Elisabeth I. Heath, MD (1)
PMID 10676951, PMID 18492108, PMID 20014148, PMID 20368434, PMID 20471824, PMID 21266718, PMID 21285985, PMID 21417856, PMID 21670202, PMID 22044694, PMID 22571487, PMID 23380277, PMID 23841899, PMID 24004666, PMID 24127483, PMID 30167756, PMID 30623229, PMID 31654285, PMID 34000073, PMID 34615429, PMID 36110959, PMID 37863903
P30CA033572 (6), P30CA068485 (3), P30CA012197 (2), P30CA022453 (2), P30CA036727 (2), N01CM62207 (1), N01CN35158 (1), P30CA008748 (1), P30CA014520 (1), P30CA015083 (1), P30CA046592 (1), P30CA082709 (1), P50CA098131 (1), R01CA080195 (1), R21CA204706 (1)